University Hospital - Steno Diabetes Center Copenhagen
Peter Rossing is a clinician researcher devoted to complications in diabetes with focus on
renal and cardiovascular complications. He obtained a specialist degree in internal medicine
and endocrinology 2004. Since 2007 he has been a chief physician and manager of the Steno
Diabetes Center research team dedicated to the research of micro-and macrovascular
complications of diabetes.
Since 2012 Professor in diabetic angiopathy at University of Copenhagen. Peter Rossing has
in epidemiological studies investigated key features of the pathophysiology of the diabetic
kidney at different stages. He has identified several markers for development of diabetic
nephropathy; making it possible to predict the individual risk. He has been involved in several
intervention studies in patients with overt diabetic nephropathy aiming at improving the
prognosis.
He was coordinator of the EU FP7 project PRIORITY demonstrating that urinary proteomics
can be used to stratify prevention of renal complications in type 2 diabetes, and the Novo
Nordisk Foundation grant PROTON aiming at personalising prevention of diabetic
nephropathy.
He has co-authored >550 papers and his h-index is 79. He received the Minkowski prize in
2005 and the Golgi prize in 2016 both from the EASD and the E. Bierman award from ADA.
Past president of the Danish Endocrine Society, and of the European Diabetic Nephropathy
Study group and chairman of the Danish National Diabetes Registry.
Presenter of 1 Presentation
Cardiorenal benefits of Finerenone - a new mineralocorticoid- antagonist in chronic kidney disease and diabetes
Session Name
Session Type
Industry Symposium
Date
Wed, 27.04.2022
Session Time
16:15 - 17:45
Room
Hall 114
Presenter
Lecture Time
16:40 - 17:00